Agios Pharmaceuticals
AGIO
#5025
Rank
HK$14.89 B
Marketcap
HK$249.51
Share price
-2.09%
Change (1 day)
-20.82%
Change (1 year)

Operating Margin for Agios Pharmaceuticals (AGIO)

Operating Margin as of October 2026 (TTM): -466.78%

According to Agios Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -466.78%. At the end of 2025 the company had an Operating Margin of -765.89%.

Operating Margin history for Agios Pharmaceuticals from 2012 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-765.89%-138.93%
20241,967.15%-249.86%
2023-1,312.63%-19.36%
2022-1,627.82%
2018-366.61%-49.89%
2017-731.60%157.64%
2016-283.97%42.59%
2015-199.14%141.34%
2014-82.51%-45.71%
2013-151.98%66.43%
2012-91.32%20.86%
2011-75.56%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.01%-102.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
42.17%-109.03%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
17.79%-103.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-153.22%-67.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
42.50%-109.10%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
4.37%-100.94%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.